Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

ClinicalTrials.gov ID: NCT00267267

Public ClinicalTrials.gov record NCT00267267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Open-Label, Multi-Center, Double-Blind, Randomized, Parallel Group Study Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin, Administered Once Daily (QD) Compared to Fixed Combination Ezetimibe/Simvastatin for 6 Weeks in Subjects With Dyslipidemia.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another.

Study identification

NCT ID
NCT00267267
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
1,784 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Not listed
Completion
Jan 2007 (Actual)
Last update posted
Dec 10, 2007

2006 – 2007

United States locations

U.S. sites
123
U.S. states
34
U.S. cities
103
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35209-7802 —
Pfizer Investigational Site Birmingham Alabama 35235 —
Pfizer Investigational Site Chandler Arizona 85224 —
Pfizer Investigational Site Mesa Arizona 85201 —
Pfizer Investigational Site Jonesboro Arkansas 72401 —
Pfizer Investigational Site Anaheim California 92804 —
Pfizer Investigational Site Escondido California 92025-4284 —
Pfizer Investigational Site Fresno California 93720 —
Pfizer Investigational Site Los Altos California 94024 —
Pfizer Investigational Site Los Angeles California 90015 —
Pfizer Investigational Site Palm Springs California 92262 —
Pfizer Investigational Site Paramount California 90723 —
Pfizer Investigational Site San Diego California 92128 —
Pfizer Investigational Site Santa Rose California 95405 —
Pfizer Investigational Site Walnut Creek California 94598 —
Pfizer Investigational Site Westlake Village California 91361 —
Pfizer Investigational Site Golden Colorado 80401 —
Pfizer Investigational Site New Haven Connecticut 06519-1600 —
Pfizer Investigational Site Newark Delaware 19713 —
Pfizer Investigational Site Washington D.C. District of Columbia 20010 —
Pfizer Investigational Site Atlantis Florida 33462 —
Pfizer Investigational Site Boca Raton Florida 33486 —
Pfizer Investigational Site Daytona Beach Florida 32114 —
Pfizer Investigational Site DeFuniak Springs Florida 32435 —
Pfizer Investigational Site Destin Florida 32541 —
Pfizer Investigational Site Lakeland Florida 33805 —
Pfizer Investigational Site Miami Florida 33136 —
Pfizer Investigational Site Miami Florida 33144 —
Pfizer Investigational Site Miami Florida 33173 —
Pfizer Investigational Site Orlando Florida 32806 —
Pfizer Investigational Site Pensacola Florida 32504-8721 —
Pfizer Investigational Site Atlanta Georgia 30309 —
Pfizer Investigational Site Atlanta Georgia 30328 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Honolulu Hawaii 96814 —
Pfizer Investigational Site Aurora Illinois 60504 —
Pfizer Investigational Site Chicago Illinois 60637 —
Pfizer Investigational Site Rockford Illinois 61108 —
Pfizer Investigational Site Springfield Illinois 62701 —
Pfizer Investigational Site Evansville Indiana 47712 —
Pfizer Investigational Site Evansville Indiana 47713 —
Pfizer Investigational Site Evansville Indiana 47714 —
Pfizer Investigational Site Des Moines Iowa 50314 —
Pfizer Investigational Site Newton Kansas 67114 —
Pfizer Investigational Site Overland Park Kansas 66210 —
Pfizer Investigational Site Pratt Kansas 67124 —
Pfizer Investigational Site Topeka Kansas 66606 —
Pfizer Investigational Site Edgewood Kentucky 41017 —
Pfizer Investigational Site Erlanger Kentucky 41018 —
Pfizer Investigational Site Louisville Kentucky 40205-3374 —
Pfizer Investigational Site Columbia Maryland 21044-2914 —
Pfizer Investigational Site Ayer Massachusetts 01432 —
Pfizer Investigational Site Boston Massachusetts 02111 —
Pfizer Investigational Site Boston Massachusetts 02114 —
Pfizer Investigational Site Milford Massachusetts 01757 —
Pfizer Investigational Site Bloomfield Hills Michigan 48302 —
Pfizer Investigational Site Grand Rapids Michigan 49525 —
Pfizer Investigational Site Troy Michigan 48098 —
Pfizer Investigational Site Brooklyn Center Minnesota 55430 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Saint Cloud Minnesota 56303-1901 —
Pfizer Investigational Site Columbia Missouri 65212 —
Pfizer Investigational Site Jefferson City Missouri 65109 —
Pfizer Investigational Site Manchester Missouri 63021 —
Pfizer Investigational Site Springfield Missouri 65804 —
Pfizer Investigational Site Springfield Missouri 65807 —
Pfizer Investigational Site Omaha Nebraska 68106 —
Pfizer Investigational Site Omaha Nebraska 68114 —
Pfizer Investigational Site Omaha Nebraska 68130 —
Pfizer Investigational Site Las Vegas Nevada 89106 —
Pfizer Investigational Site Las Vegas Nevada 89128 —
Pfizer Investigational Site Cooperstown New York 13326 —
Pfizer Investigational Site Endwell New York 13760 —
Pfizer Investigational Site Lewiston New York 14092 —
Pfizer Investigational Site Manlius New York 13104 —
Pfizer Investigational Site Rochester New York 14609 —
Pfizer Investigational Site Rochester New York 14618 —
Pfizer Investigational Site Syracuse New York 13202 —
Pfizer Investigational Site West Seneca New York 14224 —
Pfizer Investigational Site Cary North Carolina 27511 —
Pfizer Investigational Site Charlotte North Carolina 28209-3734 —
Pfizer Investigational Site Huntersville North Carolina 28078 —
Pfizer Investigational Site Monroe North Carolina 28112 —
Pfizer Investigational Site Raleigh North Carolina 27609 —
Pfizer Investigational Site Wilmington North Carolina 28412 —
Pfizer Investigational Site Winston-Salem North Carolina 27103-3315 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Cincinnati Ohio 45219 —
Pfizer Investigational Site Cleveland Ohio 44195 —
Pfizer Investigational Site Fairview Park Ohio 44126 —
Pfizer Investigational Site Beaver Pennsylvania 15009 —
Pfizer Investigational Site Bensalem Pennsylvania 19020 —
Pfizer Investigational Site Doylestown Pennsylvania 18901 —
Pfizer Investigational Site Harleysville Pennsylvania 19438 —
Pfizer Investigational Site Lancaster Pennsylvania 17603 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15213 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15224 —
Pfizer Investigational Site Sayre Pennsylvania 18840 —
Pfizer Investigational Site Lincoln Rhode Island 02865 —
Pfizer Investigational Site Providence Rhode Island 02906 —
Pfizer Investigational Site Anderson South Carolina 29621 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site Simpsonville South Carolina 29681 —
Pfizer Investigational Site Bristol Tennessee 37620 —
Pfizer Investigational Site Chattanooga Tennessee 37404 —
Pfizer Investigational Site Germantown Tennessee 38138 —
Pfizer Investigational Site Johnson City Tennessee 37601 —
Pfizer Investigational Site Memphis Tennessee 38104 —
Pfizer Investigational Site Memphis Tennessee 38119 —
Pfizer Investigational Site Memphis Tennessee 38120 —
Pfizer Investigational Site Memphis Tennessee 38128 —
Pfizer Investigational Site Selmer Tennessee 38375 —
Pfizer Investigational Site Arlington Texas 76017 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Houston Texas 77054 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site San Antonio Texas 78238 —
Pfizer Investigational Site Bountiful Utah 84010 —
Pfizer Investigational Site Salt Lake City Utah 84102 —
Pfizer Investigational Site Newport News Virginia 23606 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Renton Washington 98055 —
Pfizer Investigational Site Spokane Washington 99216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00267267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2007 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00267267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →